Structural and functional study of an anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata

Biochemistry

Volumn 44, Issue 28, 2005, Pages 9626-9636

  Hemmi, Hikaru ^a   Kumazaki, Takashi ^b   Yoshizawa Kumagaye, Kumiko ^c   Nishiuchi, Yuji ^c   Yoshida, Takuya ^d   Ohkubo, Tadayasu ^d   Kobayashi, Yuji ^d,e  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^b AOMORI UNIVERSITY   (Japan)

^c Protein Research Foundation   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; FUNCTIONAL ASSESSMENT; SOLUTIONS; SPECTROSCOPIC ANALYSIS; STRUCTURAL ANALYSIS; SYNTHESIS (CHEMICAL);

ANEMONIA ELASTASE INHIBITOR (AEI); ANEMONIA SULCATA; INHIBITORY ACTIVITIES; SOLUTION STRUCTURES;

AGENTS;

APROTININ; CYSTEINE; ELASTASE INHIBITOR; GLUTAMINE; ISOLEUCINE; METHIONINE; OVOMUCOID; PANCREATIC ELASTASE; PORCINE PANCREATIC ELASTASE; PROLINE; PROTEINASE; STREPTOMYCES PROTEINASE B; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANEMONE; ANEMONIA SULCATA; ARTICLE; BETA CHAIN; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; DISULFIDE BOND; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; STREPTOMYCES GRISEUS; STRUCTURE ACTIVITY RELATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; AVIAN PROTEINS; CRYSTALLOGRAPHY, X-RAY; DISULFIDES; HUMANS; LEUKOCYTE ELASTASE; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OVOMUCIN; PANCREATIC ELASTASE; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEA ANEMONES; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; STREPTOMYCES GRISEUS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; SWINE; TRYPSIN INHIBITOR, KAZAL PANCREATIC; TURKEYS;

ANEMONIA; ANEMONIA SULCATA; LOPHURA NYCTHEMERA; STREPTOMYCES GRISEUS; SUIDAE;

EID: 22244438235     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0472806     Document Type: Article

References (63)

1. Kolkenbrock, H., and Tschesche, H. (1987) A new inhibitor of elastase from the sea anemone (Anemonia sulcata), Biol. Chem. Hoppe-Seyler 368, 93-99.
2. Tschesche, H., Kolkenbrock, H., and Bode, W. (1987) The covalent structure of the elastase inhibitor from Anemonia sulcata: A "non-classical" Kazal-type protein, Biol. Chem. Hoppe-Seyler 368, 1297-1304.
3. Bode, W., Epp, O., Huber, R., Laskowski, M., Jr., and Ardelt, W. (1985) The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3), Eur. J. Biochem. 147, 387-395.
4. Johansson, M. W., Keyser, P., and Soderhall, K. (1994) Purification and cDNA cloning of a four-domain Kazal proteinase inhibitor from crayfish blood cells, Eur. J. Biochem. 223, 389-394.
5. Odum, L., Bundgaard, J. R., and Johnsen, A. H. (1999) A Kazal-type trypsin inhibitor from the protochordate Ciona intestinalis. Eur. J. Biochem. 259, 872-876.
6. Tamaoki, H., Miura, R., Kusunoki, M., Kyogoku, Y., Kobayashi, Y., and Moroder, L. (1998) Folding motifs induced and stabilized by distinct cystine frameworks, Protein Eng. 11, 649-659.
7. 1H NMR spectroscopy and distance geometry calculations. Protein Eng. 4, 509-518.
8. Kobayashi, Y., Sato, A., Takashima, H., Tamaoki, H., Nishimura, S., Kyogoku, Y., Ikenaka, K., Kondo, T., Mikoshiba, K., Hojo, H., Aimoto, S., and Moroder, L. (1991) A new α-helical motif in membrane active peptides, Neurochem. Int. 18, 525-534.
9. Kobayashi, Y., Takashima, H., Tamaoki, H., Kyogoku, Y., Lambert, P., Kuroda, H., Chino, N., Watanabe, T. X., Kimura, T., Sakakibara, S., and Moroder, L. (1991) The cystine stabilized α-helix. A common structural motif of ion channel blocking neurotoxic peptides, Biopolymers 31, 1213-1220.
10. Pease, J. H., and Wemmer, D. E. (1988) Solution structure of apamin determined by nuclear magnetic resonance and distance geometry, Biochemistry 27, 8491-8498.
11. Takashima, H., Kobayashi, Y., Tamaoki, H., Kyogoku, Y., Lambert, P., Kuroda, H., Chino, N., Watanabe, T. X., Kimura, T., and Sakakibara, S. (1991) Solution structure of charybdotoxin determined by NMR and distance geometry, in Peptides 1990 (Giralt, E., and Andreu, D., Eds.) pp 557-559, ESCOM, Leiden, The Netherlands.
12. 1H NMR: A structural motif common to toxic arthropod proteins, Biochemistry 32, 715-724.
13. Friedrich, T., Kroger, B., Bialojan, S., Lemaire, H. G., Hoffken, H. W., Reuscenbach, P., Otte, M., and Dodt, J. (1993) A Kazal-type inhibitor with thrombin specificity from Rhodnius prolixus, J. Biol. Chem. 268, 16216-16222.
14. Sommerhoff, C. P., Sollner, C., Mentele, R., Piechottka, G. P., Auerswald, E. A., and Fritz, H. (1994) A Kazal-type inhibitor of human mast cell tryptase: Isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis, Biol. Chem. Hoppe-Seyler 375, 685-694.
15. Hemmi, H., Yoshida, T., Kumazaki, T., Nemoto, N., Hasegawa, J., Nishioka, F., Kyogoku, Y., Yokosawa, H., and Kobayashi, Y. (2002) Solution structure of ascidian trypsin inhibitor determined by nuclear magnetic resonance spectroscopy, Biochemistry 41, 10657-10664.
16. 39 bond, Biochemistry 42, 2524-2534.
17. Laskowski, M., Jr., Kato, I., Ardelt, W., Cook, J., Denton, A., Empie, M. W., Kohr, W. J., Park, S. J., Parks, K., Schatzley, B. L., Schoenberger, O. L., Tashiro, M., Vichot, G., Whatkey, H. F., Wieczorek, A., and Wieczorek, M. (1987) Ovomucoid third domains from 100 avian species: Isolation, sequences, and hypervariability of enzyme-inhibitor contact residues, Biochemistry 26, 202-221.
18. Dawson, P. E., Muir, T. W., Clark-Lewis, I., and Kent, S. B. (1994) Synthesis of proteins by native chemical ligation. Science 266, 776-779.
19. Narahashi, Y. (1970) Pronase, Methods Enzymol. 19, 651-664.
20. Bender, M. L., Begue-Canton, M. L., Blakeley, R. L., Brubacher, L. J., Feder, J., Gunter, C. R., Kezdy, F. J., Killheffer, J. V., Jr., Marshall, T. H., Miller, C. G., Roeske, R. W., and Stoops, J. K. (1966) The determination of the concentration of hydrolytic enzyme solutions: α-Chymotrypsin, trypsin, papain, elastase, subtilisin, and acetylcholinesterase, J. Am. Chem. Soc. 88, 5890-5913.
21. Chase, T., Jr., and Shaw, E. (1970) Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl, Methods Enzymol. 19, 20-27.
22. Bieth, J. G. (1995) Theoretical and practical aspects of proteinase inhibition kinetics, Methods Enzymol. 248, 59-84.
23. 1H spin-spin coupling constants in proteins, Biochem. Biophys. Res. Commun. 113, 967-974.
24. Marion, D., Ikura, M., Tschundin, R., and Bax, A. (1989) Rapid recording of 2D NMR spectra without phase cycling. Application to the study of hydrogen exchange in proteins, J. Magn. Reson. 85, 393-399.
25. 1H NMR spectra of proteins via double quantum filtering, Biochem. Biophys. Res. Commun. 117, 479-485.
26. Davis, D. G., and Bax, A. (1985) Assignment of complex proton NMR spectra via two-dimensional homonuclear Hartmann-Hahn spectroscopy, J. Am. Chem. Soc. 107, 2820-2821.
27. Kumar, A., Ernst, R. R., and Wüthrich, K. (1980) A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules, Biochem. Biophys. Res. Commun. 95, 1-6.
28. Griesinger, C., and Ernst, R. R. (1987) Frequency offset effects and their elimination in NMR rotating-frame cross-relaxation spectroscopy, J. Magn. Reson. 75, 261-271.
29. Griesinger, C., Sorensen, O. W., and Ernst, R. R. (1987) Practical aspects of the E.COSY technique. Measurement of scalar spin-spin coupling constants in peptides, J. Magn. Reson. 75, 474-492.
30. Piotto, M., Saudek, V., and Sklenar, V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2, 661-665.
31. 15N HSQC experiments optimized to retain full sensitivity, J. Magn. Reson. 102, 241-245.
32. Bodenhausen, G., and Ruben, D. J. (1980) Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy, Chem. Phys. Lett. 69, 185-189.
33. Wüthrich, K., Billetter, M., and Braun, W. (1983) Pseudostructures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance, J. Mol. Biol. 169, 949-961.
34. Clore, G. M., Gronenborn, A. M., Nilges, M., and Ryan, C. A. (1987) Three-dimensional structure of potato carboxypeptidase inhibitor in solution. A study using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics, Biochemistry 26, 8012-8013.
35. Wagner, G., Braun, W., Havel, T. F., Schaumman, T., Go, N., and Wüthrich, K. (1987) Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide fold of the basic pancreatic trypsin inhibitor determined using two different algorithms, DISGEO and DISMAN, J. Mol. Biol. 196, 611-639.
36. Brünger, A. T. (1992) X-PLOR. A system for X-ray crystallography and NMR, Yale University Press, New Haven, CT.
37. Laskowski, R. A., Rullmann, J. A. C., MacArthur, M. W., Kaptein, R., and Thornton, J. M. (1996) AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR, J. Biomol. NMR 8, 477-486.
38. Koradi, R., Billeter, M., and Wüthrich, K. (1996) MOLMOL: A program for display and analysis of macromolecular structures, J. Mol. Graphics 14, 51-55.
39. Kraulis, P. J. (1991) MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures, J. Appl. Crystallogr. 24, 946-950.
40. Read, R. J., and James, M. N. G. (1986) Introduction to the protein inhibitors: X-ray crystallography, in Protease inhibitors (Barrett, A. J., and Salvesen, G., Eds.) pp 301-336, Elsevier, Amsterdam.
41. Baker, M. B., and Murphy, K. P. (1997) Dissecting the energetics of a protein-protein interaction: The binding of ovomucoid third domain to elastase, J. Mol. Biol. 268, 557-569.
42. Wade, J. D., Bedford, J., Sheppard, R. C., and Tregear, G. W. (1991) DBU as an N α-deprotecting reagent for the fluorenyl-methoxycarbonyl group in continuous flow solid-phase peptide synthesis, Pept. Res. 4, 194-199.
43. Lauer, J. L., Fields, C. G., and Fields, G. B. (1995) Sequence dependence of aspartimide formation during 9-fluorenylmethoxy-carbonyl solid-phase peptide synthesis, Lett. Pept. Sci. 1, 197-205.
44. im-benzyloxymethyl group during synthesis of peptides containing cysteinyl residue at the N-terminus, Pept. Res. 4, 84-87.
45. im-benzyloxymethyl(Bom) group, Pept. Chem. 4, 61-66.
46. Empie, M. W., and Laskowski, M., Jr. (1982) Thermodynamics and kinetics of single residue replacements in avian ovomucoid third domains: Effect on inhibitor interactions with serine proteinases, Biochemistry 21, 2274-2284.
47. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons, New York.
48. Fink, E., Rehm, H., Gippner, C., Bode, W., Eulitz, M., Machleidt, W., and Fritz, H. (1986) The primary structure of bdellin B-3 from the leech Hirudo medicinalis. Bdellin B-3 is a compact proteinase inhibitor of a "non-classical" Kazal type. It is present in the leech in a high molecular mass form, Biol. Chem. Hoppe-Seyler 367, 1235-1242.
49. Mende, K., Petoukhova, O., Koulitchkova, V., Schaub, G. A., Lange, U., Kaufmann, R., and Nowak, G. (1999) Dipetalogastin, a potent thrombin inhibitor from the blood-sucking insect Dipetalogaster maximus: cDNA cloning, expression and characterization, Eur. J. Biochem. 266, 583-590.
50. Tsunemi, M., Kato, H., Nishiuchi, Y., Kumagaye, S., and Sakakibara, S. (1992) Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitor, Biochem. Biophys. Res. Commun. 185, 967-973.
51. Tan, N. H., and Kaiser, E. T. (1976) Studies on the solid-phase synthesis of bovine pancreatic trypsin inhibitor (Kunitz) and the characterization of the synthetic material, J. Org. Chem. 41, 2787-2793.
52. De Filippis, V., Vindigni, A., Altichieri, L., and Fontana, A. (1995) Core domain of hirudin from the leech Hirudinaria manillensis: Chemical synthesis, purification, and characterization of a Trp3 analog of fragment 1-47, Biochemistry 34, 9552-9564.
53. Heinz, D. W., Hyberts, S. G., Peng, J. W., Priestle, J. P., Wagner, G., and Grutter, M. G. (1992) Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: Functional and structural investigation, Biochemistry 31, 8755-8766.
54. Kojima, S., Kumagai, I., and Miura, K. (1993) Requirement for a disulfide bridge near the reactive site of protease inhibitor SSI (Streptomyces subtilisin inhibitor) for its inhibitory action, J. Mol. Biol. 230, 395-399.
55. Kojima, S., Obata, S., Kumagai, I., and Miura, K. (1990) Alteration of the specificity of the Streptomyces subtilisin inhibitor by gene engineering, Biotechnology 8, 449-452.
56. Kowalski, D., Leary, T. R., McKee, R. E., Sealock, R. W., Wang, D., and Laskowski, M., Jr. (1974) Replacements, insertions, and modifications of amino acid residues in the reactive site of soybean trypsin inhibitor (Kunitz), in Proceedings of Bayer Symposium, V. Protease Inhibitors (Fritz, H., Tschesche, H., Greene, L. J., and Truscheit, E., Eds.) pp 311-324, Springer, Berlin.
57. Jallat, S., Carvallo, D., Tessier, L. H., Roecklin, D., Roitsch, C., Ogushi, F., Crystal, R. G., and Courtney, M. (1986) Altered specificities of genetically engineered α1 antitrypsin variants, Protein Eng. 1, 29-35.
58. von Wilcken-Bergmann, B., Tilis, D., Sartorius, J., Auerwald, E. A., Schroder, W., and Müller-Hill, B. (1986) A synthetic operon containing 14 bovine pancreatic trypsin inhibitor genes is expressed in E. coli, EMBO J. 5, 3219-3225.
59. Longstaff, C., Campbell, A. F., and Fersht, A. R. (1990) Recombinant chymotrypsin inhibitor 2: Expression, kinetic analysis of inhibition with α-chymotrypsin and wild-type and mutant subtilisin BPN′, and protein engineering to investigate inhibitory specificity and mechanism, Biochemistry 29, 7339-7347.
60. Bode, W., Wei, A.-Z., Huber, R., Meyer, E., Travis, J., and Neumann, S. (1986) X-ray structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor, EMBO J. 5, 2453-2458.
61. Read, R. J., Fujinaga, M., Sielecki, A. R., and James, M. N. G. (1983) Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8-Å resolution, Biochemistry 22, 4420-4433.
62. Fujinaga, M., Sielecki, A. R., Read, R. J., Ardelt, W., Laskowski, M., Jr., and James, M. N. G. (1987) Crystal and molecular structures of the complex of α-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 Å resolution, J. Mol. Biol. 195, 397-418.
63. Bode, W., Meyer, E., Jr., and Powers, J. C. (1989) Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors, Biochemistry 28, 1951-1963.